-
Mashup Score: 0Cardiac output improvement by pecavaptan: a novel dual‐acting vasopressin V1a/V2 receptor antagonist in experimental heart failure - 4 year(s) ago
Graphical abstract demonstrating the beneficial effect of dual vasopressin antagonism. AVP, arginine vasopressin; CO, cardiac output; TPR, total peripheral resistance; UV, urine volume.
Source: Wiley Online LibraryCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Risk and Risk Reduction In Trials of Heart Failure with Reduced Ejection Fraction: Absolute or Relative? - 4 year(s) ago
Click on the article title to read more.
Source: Wiley Online LibraryCategories: Cardiologists, Latest HeadlinesTweet-
A summary of practice-changing #HFrEF pharma #RCTs, eligibility criteria, baseline event rates, and treatment effect for each outcome is buried in the supplement (mammoth table!). Thank you @MarcoMetra for efficient peer review at #EJHF #HeartFailure https://t.co/pidwjilTEv 4/4 https://t.co/L2k3NdfX7q
-
-
Mashup Score: 3
Diagnosis and treatment of cardiac amyloidosis.
Source: Wiley Online LibraryCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#HeartFailure spotlight on cardiac #amyloidosis: how to diagnose and treat patients with cardiac involvement of amyloidosis https://t.co/3ffLWVXK50 #EJHF #cardiotwitter #medtwitter @MarcoMetra @HFA_President @kevin_damman https://t.co/0792XVULjo
-
-
Mashup Score: 3Pharmacotherapy for heart failure with reduced ejection fraction and health‐related quality of life: a systematic review and meta‐analysis - 4 year(s) ago
Aims The aim of this study was to synthesize the evidence on the effect of heart failure with reduced ejection fraction (HFrEF) pharmacotherapy on health-related quality of life (HRQoL). Methods an…
Source: Wiley Online LibraryCategories: Cardiology News and Journals, Latest HeadlinesTweet-
More than meets the eye: QoL improvement by guideline-recommended medical therapy in #HeartFailure https://t.co/1BaC4q9g3c @MarcoMetra @HFA_President @kevin_damman #EJHF #cardiotwitter https://t.co/tNb6CMrIXM
-
-
Mashup Score: 0Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA - 4 year(s) ago
Angiotensin receptor–neprilysin inhibition has been shown to be superior to target doses of an ACE inhibitor in reducing the risk of cardiovascular death and clinical disease progression in patients …
Source: Wiley Online LibraryCategories: Cardiologists, Latest HeadlinesTweet-
Reanalysis of PARADIGM‐HF at the chronological midpoint as 2 distinct sequentially executed trials reached near identical findings In fact, PARADIGM-HF could be randomly split into 4, & each could demonstrate CVd ↓ with S/V Prof. Milton Packer in #EJHF: https://t.co/RTiubqWg8f https://t.co/ghaTpmxfpL
-
-
Mashup Score: 1
Cardiovascular Cell Therapy Research Network: the CONCERT‐HF trial. CONCERT‐HF is the first multicentre trial assessing c‐kit positive cardiac cells (CPCs) and a combination of two cell types from di…
Source: Wiley Online LibraryCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Music to your ears? The effect of infusion of bone marrow derived cells in #HeartFailure - effect on AEs/QoL, but not LVEF - CONCERT-HF Study. https://t.co/3xR2PDTrje #EJHF #cardiotwitter @MarcoMetra @HFA_President @kevin_damman https://t.co/C9vQmSFwaR
-
-
Mashup Score: 3European Journal of Heart Failure: Call for Editor-in-Chief - 4 year(s) ago
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The perfect match? #EJHF is looking for its next Editor-in-Chief. Your professional excellence, experience and leadership skills may be exactly what the journal is looking for. Apply by 3 May https://t.co/ODdGin4vbK #HFA_ESC #cardiotwitter #heartfailure #cardiology https://t.co/EmHaNnrdxK
-
-
Mashup Score: 0
NT‐proBNP is frequently elevated in patients with COVID‐19, and is strongly associated with myocardial injury and all‐cause mortality.
Source: Wiley Online LibraryCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A #HeartFailure biomarker in the risk stratification of #COVID19 patients - #NTproBNP frequently high and associated with outcome in these patients https://t.co/mjzLqCv5kV @MarcoMetra @HFA_President @kevin_damman #EJHF https://t.co/BLDH1NABq9
-
-
Mashup Score: 1Heart failure treatment up‐titration and outcome and age: an analysis of BIOSTAT‐CHF - 4 year(s) ago
Aims Several studies have shown that older patients with heart failure with reduced ejection fraction (HFrEF) are undertreated. The aim of this study was to evaluate the association of up‐titration …
Source: Wiley Online LibraryCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Should age be considered when treating #HeartFailure patients with #betablocker therapy? Data from BIOSTAT in #EJHF suggest no dose response relationship with higher age for #betablocker therapy. Is there an optimal dose-age relationship for betablockers? https://t.co/OANNpZrESv https://t.co/AcC12sHahH
-
-
Mashup Score: 0
Aims To determine whether a strategy of intensive blood pressure control reduces the risk of heart failure (HF) events consistently across the spectrum of kidney function and albuminuria. Methods a…
Source: Wiley Online LibraryCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Manage blood pressure intensively to prevent #HeartFailure, even when renal function is poor - read the secondary analysis from SPRINT in #EJHF https://t.co/gvkPsUcWbx @MarcoMetra @HFA_President @kevin_damman @mvaduganathan #cardiotwitter https://t.co/IlAF6xHfx4
-
Return of the Vaptans in #HeartFailure? Favourable effects of pecavaptan in experimental HF https://t.co/MgtRD5dMwo @MarcoMetra @HFA_President @kevin_damman #EJHF #cardiotwitter https://t.co/kl3kWkR6cp